Advancements in the treatment of age-related macular degeneration: a comprehensive review

医学 黄斑变性 血管抑制剂 地理萎缩 失明 心理干预 加药 重症监护医学 叙述性评论 眼科 贝伐单抗 验光服务 药理学 外科 精神科 化疗
作者
Christos Papaioannou
出处
期刊:Postgraduate Medical Journal [Oxford University Press]
被引量:2
标识
DOI:10.1093/postmj/qgae016
摘要

Abstract Age-related macular degeneration (AMD) stands as a leading cause of irreversible blindness, particularly affecting central vision and impeding daily tasks. This paper provides a thorough exploration of AMD, distinguishing between its two main subtypes—Wet and Dry AMD—while shedding light on the prevalence and risk factors, including age, genetics, and smoking. The focus shifts to the current and future treatment landscape, examining both Dry and Wet AMD. Regarding Dry AMD, interventions such as antioxidant supplementation and ongoing clinical trials offer hope. Notable among these is Pegcetacoplan which is the only Food and Drug Administration (FDA)-approved medication, displaying promising results in reducing geographic atrophy lesions. For Wet AMD, anti-Vascular Endothelial Growth Factor therapies like Ranibizumab (Lucentis®) have been instrumental, and newer drugs like Faricimab and OPT-302 show comparable efficacy with extended dosing intervals. Additionally, gene therapies such as RGX-314 present a potential paradigm shift, reducing or eliminating the need for frequent injections. Biosimilars offer cost-effective alternatives. The paper also delves into the integration of technology and artificial intelligence in AMD management, highlighting the role of smartphone apps for patient monitoring and artificial intelligence algorithms for diagnosis and surveillance. Furthermore, patient perspectives on artificial intelligence demonstrate a positive correlation between understanding and trust. The narrative concludes with a glimpse into ground-breaking technologies, including retinal implants and bionic chips, offering hope for vision restoration. Overall, this paper underscores the multifaceted approach in addressing AMD, combining traditional and innovative strategies, paving the way for a more promising future in AMD treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Hello应助yyg采纳,获得10
刚刚
笨笨驳回了顾矜应助
1秒前
1秒前
李健应助沐夏采纳,获得10
1秒前
wanci应助昵称采纳,获得10
2秒前
xunl完成签到,获得积分10
2秒前
vvvvvv发布了新的文献求助20
3秒前
轩然发布了新的文献求助10
4秒前
英俊的铭应助李喜喜采纳,获得10
5秒前
Orange应助shell采纳,获得10
5秒前
888发布了新的文献求助10
6秒前
慕青应助研友_LmeK4L采纳,获得10
7秒前
wen完成签到,获得积分10
7秒前
9秒前
9秒前
9秒前
科研通AI5应助科研通管家采纳,获得10
10秒前
顾矜应助科研通管家采纳,获得10
10秒前
bkagyin应助陈小司采纳,获得10
10秒前
SciGPT应助科研通管家采纳,获得10
10秒前
华仔应助科研通管家采纳,获得10
10秒前
11秒前
CipherSage应助科研通管家采纳,获得10
11秒前
搜集达人应助科研通管家采纳,获得10
11秒前
共享精神应助科研通管家采纳,获得10
11秒前
今后应助科研通管家采纳,获得10
11秒前
Jasper应助科研通管家采纳,获得10
11秒前
Lucas应助科研通管家采纳,获得10
11秒前
顾矜应助科研通管家采纳,获得10
11秒前
ZhouYW应助科研通管家采纳,获得10
12秒前
科研通AI5应助科研通管家采纳,获得10
12秒前
12秒前
12秒前
土拨鼠发布了新的文献求助10
12秒前
赘婿应助科研通管家采纳,获得30
12秒前
赘婿应助科研通管家采纳,获得10
12秒前
天天快乐应助科研通管家采纳,获得10
12秒前
wanci应助科研通管家采纳,获得10
12秒前
共享精神应助科研通管家采纳,获得10
13秒前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Introduction to Strong Mixing Conditions Volumes 1-3 500
China—Art—Modernity: A Critical Introduction to Chinese Visual Expression from the Beginning of the Twentieth Century to the Present Day 430
Tip60 complex regulates eggshell formation and oviposition in the white-backed planthopper, providing effective targets for pest control 400
A Field Guide to the Amphibians and Reptiles of Madagascar - Frank Glaw and Miguel Vences - 3rd Edition 400
China Gadabouts: New Frontiers of Humanitarian Nursing, 1941–51 400
The Healthy Socialist Life in Maoist China, 1949–1980 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3797758
求助须知:如何正确求助?哪些是违规求助? 3343236
关于积分的说明 10315046
捐赠科研通 3059985
什么是DOI,文献DOI怎么找? 1679200
邀请新用户注册赠送积分活动 806411
科研通“疑难数据库(出版商)”最低求助积分说明 763150